In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was achieved with minimal disruption and substantial cost saving to our healthcare partners.
Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test...
Transitioned all 6 CTS labs from an investigational new drug (IND) to a licensed Zika test, and anno...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
CTS Research Consortium was established to further CTS’s leadership in infectious disease research....
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...